QIAsymphony DSP Circulating DNA Kit – our new solution for expanding your insight
Circulating cell-free DNA (ccfDNA) is a promising new tool for diagnostic researchers. Collected in minimally invasive liquid biopsy samples, ccfDNA holds great potential for detection and monitoring of cancer biomarkers and other diseases. QIAsymphony SP and the QIAsymphony DSP Circulating DNA Kit automate your ccfDNA purification, streamlining and standardizing your workflow.
Your efficient sample to insight ccfDNA solution.
Learn more
Automated ccfDNA purification – driving advances in colorectal cancer testing
Dr. Lawrence La Pointe, President and CEO of Clinical Genomics, presents an overview of colorectal cancer testing and highlights the significance of circulating tumor DNA. Colvera, their new blood-based test for monitoring disease recurrence, uses QIAsymphony SP/AS for sample purification and assay setup.
"The first step involves extracting DNA from relatively very large volumes of plasma. Developing technologies in partnership with QIAGEN to handle that high volume was really enabling for us to continue our work."
"The first step involves extracting DNA from relatively very large volumes of plasma. Developing technologies in partnership with QIAGEN to handle that high volume was really enabling for us to continue our work."
Looking for more information on our new QIAsymphony DSP Circulating DNA Kit?
See the QIAsymphony DSP Circulating DNA Kit page for ordering information and additional product details.
Visit the product page